It also lowered other cardiovascular disease (CVD) risk factors, including the alternate blood lipid targets of non‐high‐density lipoprotein cholesterol by 14% and ApoB (apolipoprotein B) by 15%, and CRP (C‐reactive protein) by 32%.8 This evidence concerns the gene APOB and cardiovascular disorder.